76
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer

, , , &

References

  • Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci. 2018; 6(31):1–113. doi:10.3390/medsci6020031.
  • Lund EK, Belshaw NJ, Elliott GO, et al. Recent advances in understanding the role of diet and obesity in the development of colorectal cancer. Proc Nutr Soc. 2011;70(2):194–204. doi:10.1017/S0029665111000073.
  • Watson AJ, Collins PD. Colon cancer: a civilization disorder. Dig Dis. 2011;29(2):222–228. doi:10.1159/000323926.
  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166.
  • Harmon BE, Wirth MD, Boushey CJ, et al. The dietary inflammatory index is associated with colorectal cancer risk in the multiethnic cohort. J Nutr. 2017;147(3):430–438. doi:10.3945/jn.116.242529.
  • Chan DS, Lau R, Aune D, et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One. 2011;6(6):e20456: doi:10.1371/journal.pone.0020456.
  • Ferrucci LM, Sinha R, Huang WY, et al. Meat consumption and the risk of incident distal colon and rectal adenoma. Br J Cancer. 2012;106(3):608–616. doi:10.1038/bjc.2011.549.
  • Constance J, Wei C, Joe E, et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207. doi:10.1007/s10552-013-0201-5.
  • Fatica A, Tollervey D, Dlakić M. PIN domain of Nob1p is required for D-site cleavage in 20S pre-rRNA. RNA. 2004;10(11):1698–1701. doi:10.1261/rna.7123504.
  • Thomas V, Roman M, Wurm JP, et al. Structural and functional analysis of the archaeal endonuclease Nob1. Nucleic Acids Res. 2012;40:3259–3274. doi:10.1093/nar/gkr1186.
  • Dongxia Y, Guixia MA. Effects of NOB1 on apoptosis and glycolysis in human cervical cancer cells. Oncol. Progr. 2018; 16(6):694–698.
  • Lin Y, Xu T, Zhou S, et al. MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1. Oncotarget. 2017;8(60):101649–101658. doi:10.18632/oncotarget.21417.
  • Kong R, Liu W, Guo Y, et al. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer. Oncol Rep. 2017;38(4):2572–2580. doi:10.3892/or.2017.5927.
  • Liu K, Chen HL, Gu MM, et al. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer. J. Chemother. 2016;28(3):225–229. 1973947815Y0000000041, doi:10.1179/1973947815Y.0000000041.
  • Zhao LJ, Zhifeng L, Rongya S. Expression of NOB1 in liver cancer tissues and its significance. Linchuang Gandanbing Zazhi. 2016;32:739–741.
  • Bubici C, Papa S. JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol. 2014;171(1):24–37. doi:10.1111/bph.12432.
  • Guo M, Li Z, Huang Y, et al. Polysaccharides from Nostoc commune Vaucher activate macrophages via NF-κB and AKT/JNK1/2 pathways to suppress colorectal cancer growth in vivo. Food Funct. 2019;10:4269–4279. doi:10.1039/C9FO00595A.
  • Zhou C, Chen Z, Lu X, et al. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells. Tumor Biol. 2016;37(3):3135–3144. : doi:10.1007/s13277-015-4134-3.
  • Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72(2):379–386. doi:10.1158/0008-5472.CAN-11-1982.
  • Gao X, Wang J, Bai W, et al. NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway. Oncol Rep. 2016;35(6):3313–3320. doi:10.3892/or.2016.4707.
  • Xiao-Wen Feng Qiao-Ling Yuan-Wei J. Ting NOB1 is essential for the survival of RKO colorectal cancer cells. World J Gastroenterol. 2015;21:868–877. doi:10.3748/wjg.v21.i3.868.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.
  • Du W, Pang C, Xue Y, et al. Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells. Oncol. Lett. 2015;10(5):3266–3270. doi:10.3892/ol.2015.3699.
  • Li W, Liu M, Feng Y, et al. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer. 2014;111(6):1188–1200. doi:10.1038/bjc.2014.382.
  • Lu ZM, Guo QY, Shi AZ, et al. Downregulation of NIN/RPN12 binding protein inhibit the growth of human hepatocellular carcinoma cells. Mol Biol Rep. 2012;39(1):501–507. doi:10.1007/s11033-011-0764-8.
  • Wang H, Li P, Zhao B. Knockdown of NOB1 expression by RNAi inhibits cellular proliferation and migration in human gliomas. Gene. 2013;528(2):146–153. doi:10.1016/j.gene.2013.07.032.
  • Zhou J, Xu T, Yan Y, et al. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the nin one binding protein (NOB1). PLoS One. 2013;8(7):e68469. doi:10.1371/journal.pone.0068469.
  • Meng W, Wang PS, Liu J, et al. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo. Oncol Rep. 2014;32(6):2411–2420. doi:10.3892/or.2014.3483.
  • Wu DP, He XW. [Expression of NOB1 and its significance in colorectal cancer]. Nan Fang Yi Ke Da Xue Xue Bao. 2012;32(3):420–422.
  • Liu Y, Huang H, Yuan B, et al. Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells. Z Gastroenterol. 2014;52:429. doi:10.1055/s-0033-1356338.
  • Li Y, Ma C, Qian M, et al. Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo. Oncol Rep. 2014;31(3):1271–1276. doi:10.3892/or.2014.2991.
  • Zhang X, Zhang D, Qu F, et al. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells. Mol Cell Biochem. 2014;396(1-2):1–8. doi:10.1007/s11010-014-2126-z.
  • Wu L, Hui H, Wang LJ, et al. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein. Oncol Rep. 2015;33(5):2309–2318. doi:10.3892/or.2015.3840.
  • Granneman S, Nandineni MR, Baserga SJ. The putative NTPase Fap7 mediates cytoplasmic 20S pre-rRNA processing through a direct interaction with Rps14. Mol Cell Biol. 2005;25:10352–10364. doi:10.1128/MCB.25.23.10352-10364.2005.
  • Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. 2007;26(22):3279–3290. doi:10.1038/sj.onc.1210421.
  • Maundrell K, Antonsson B, Magnenat E, et al. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem. 1997;272(40):25238–25242. doi:10.1074/jbc.272.40.25238.
  • Lu TH, Tseng TJ, Su CC, et al. Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways. Toxicol. Lett. 2014;224(1):130–140. doi:10.1016/j.toxlet.2013.10.013.
  • Marusiak AA, Stephenson NL, Baik H, et al. Recurrent MLK4 loss-of-function mutations suppress JNK signaling to promote colon tumorigenesis. Cancer Res. 2016;76(3):724–735. doi:10.1158/0008-5472.CAN-15-0701-T.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.